Copyright © 2001 by the European Society of Cardiology.
Letter to the Editors
Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial
a Royal Free Hospital, London, U.K.
b St. Thomas' Hospital, London, U.K.
c Queens Hospital, Burton-on-Trent, U.K.
References
- Waters D. Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. Eur Heart J. 2000;21:10291031
[Free Full Text] - Pitt B, Waters D, Brown WV. McCormick LS for the Atorvastatin versus Revascularization Treatment Investigators. Aggressive lipid-lowering compared with angioplasty in stable coronary artery disease. N Engl J Med. 199;341:7076
- Windecker S, Maier-Rudolph W, Bonzel T. Interventional Cardiology in Europe 1995. Working group Coronary Circulation of the European Society of Cardiology. Eur Heart J. 1999;20:484495
[Abstract/Free Full Text] - Lancet. 1997;350:461468[CrossRef][Web of Science][Medline]
- Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. Br Med J. 2000;321:7377
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||